NO20030115D0 - Kontrastmiddel - Google Patents
KontrastmiddelInfo
- Publication number
- NO20030115D0 NO20030115D0 NO20030115A NO20030115A NO20030115D0 NO 20030115 D0 NO20030115 D0 NO 20030115D0 NO 20030115 A NO20030115 A NO 20030115A NO 20030115 A NO20030115 A NO 20030115A NO 20030115 D0 NO20030115 D0 NO 20030115D0
- Authority
- NO
- Norway
- Prior art keywords
- imaging agents
- formula
- moiety
- angiotensin
- affinity
- Prior art date
Links
- 239000012216 imaging agent Substances 0.000 title 1
- 102000008873 Angiotensin II receptor Human genes 0.000 abstract 1
- 108050000824 Angiotensin II receptor Proteins 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Light Receiving Elements (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
| AT04701136T ATE425770T1 (de) | 2003-01-09 | 2004-01-09 | Kontrastmittel |
| US10/541,949 US7919071B2 (en) | 2003-01-09 | 2004-01-09 | Contrast agent |
| CNA2004800019549A CN1723043A (zh) | 2003-01-09 | 2004-01-09 | 造影剂 |
| PCT/NO2004/000002 WO2004062568A2 (en) | 2003-01-09 | 2004-01-09 | Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| JP2006500737A JP2006517539A (ja) | 2003-01-09 | 2004-01-09 | 造影剤 |
| DE602004020049T DE602004020049D1 (de) | 2003-01-09 | 2004-01-09 | Kontrastmittel |
| EP04701136A EP1581262B1 (de) | 2003-01-09 | 2004-01-09 | Kontrastmittel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20030115D0 true NO20030115D0 (no) | 2003-01-09 |
Family
ID=19914362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030115A NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Kontrastmiddel |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7919071B2 (de) |
| EP (1) | EP1581262B1 (de) |
| JP (1) | JP2006517539A (de) |
| CN (1) | CN1723043A (de) |
| AT (1) | ATE425770T1 (de) |
| DE (1) | DE602004020049D1 (de) |
| NO (1) | NO20030115D0 (de) |
| WO (1) | WO2004062568A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO20034350D0 (no) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optisk avbilding av kolorektal kreft |
| JP2007512321A (ja) * | 2003-11-24 | 2007-05-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 造影剤 |
| ATE447417T1 (de) * | 2004-03-04 | 2009-11-15 | Ge Healthcare As | Konjugate von angiotensin-peptid analoga und chelatbildner für diagnose und therapie |
| FR2902428B1 (fr) * | 2006-06-15 | 2008-08-15 | Servier Lab | Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN101536563A (zh) * | 2006-11-13 | 2009-09-16 | Lm爱立信电话有限公司 | 无线电信系统 |
| WO2008072973A2 (en) * | 2006-12-11 | 2008-06-19 | Ge Healthcare As | Radiolabelled peptide based compounds and uses thereof |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) * | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| GB201103696D0 (en) | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| WO2019134765A1 (en) | 2018-01-08 | 2019-07-11 | Julius-Maximilians-Universitaet Wuerzburg | Sartan analogue |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0365378A (ja) * | 1989-08-04 | 1991-03-20 | Tokyo Tatsuno Co Ltd | 複写伝票 |
| US5808091A (en) * | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
| JPH09165378A (ja) | 1995-12-15 | 1997-06-24 | Seitai Kinou Kenkyusho:Kk | N1−[18f]フルオロベンジル複素環化合物およびそれらの製造法 |
| ATE314097T1 (de) * | 1996-10-28 | 2006-01-15 | Amersham Health As | Kontrastmittel |
| CA2405469C (en) | 2000-04-12 | 2012-03-20 | Amersham Health As | Integrin binding peptide derivatives |
| WO2001092283A2 (en) | 2000-05-31 | 2001-12-06 | Mayo Foundation For Medical Education And Research | Cobalamin compounds useful as cardiovascular agents and as imaging agents |
| GB0031592D0 (en) * | 2000-12-28 | 2001-02-07 | Nycomed Amersham Plc | Stabilised radiopharmaceutical compositions |
| GB0105224D0 (en) | 2001-03-02 | 2001-04-18 | Nycomed Amersham Plc | Improved peptide-chelate conjugates |
| GB0116815D0 (en) * | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| BRPI0210886B8 (pt) * | 2001-07-10 | 2021-05-25 | Amersham Health As | composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal |
-
2003
- 2003-01-09 NO NO20030115A patent/NO20030115D0/no unknown
-
2004
- 2004-01-09 CN CNA2004800019549A patent/CN1723043A/zh active Pending
- 2004-01-09 WO PCT/NO2004/000002 patent/WO2004062568A2/en not_active Ceased
- 2004-01-09 DE DE602004020049T patent/DE602004020049D1/de not_active Expired - Lifetime
- 2004-01-09 AT AT04701136T patent/ATE425770T1/de not_active IP Right Cessation
- 2004-01-09 JP JP2006500737A patent/JP2006517539A/ja active Pending
- 2004-01-09 EP EP04701136A patent/EP1581262B1/de not_active Expired - Lifetime
- 2004-01-09 US US10/541,949 patent/US7919071B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004062568A2 (en) | 2004-07-29 |
| US20070020176A1 (en) | 2007-01-25 |
| JP2006517539A (ja) | 2006-07-27 |
| US7919071B2 (en) | 2011-04-05 |
| EP1581262A2 (de) | 2005-10-05 |
| CN1723043A (zh) | 2006-01-18 |
| EP1581262B1 (de) | 2009-03-18 |
| DE602004020049D1 (de) | 2009-04-30 |
| WO2004062568A3 (en) | 2004-09-30 |
| ATE425770T1 (de) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04000173A (es) | Compuestos basados en peptidos. | |
| NO20073039L (no) | Kontrastmidler | |
| ATE425770T1 (de) | Kontrastmittel | |
| DK1272507T3 (da) | Integrinbindende peptidderivater | |
| ATE439868T1 (de) | Targetingmittel für molekulare bilderzeugung | |
| ATE314097T1 (de) | Kontrastmittel | |
| IL173029A0 (en) | Imaging agents | |
| WO1998018497A3 (en) | Contrast agents | |
| DE602005024279D1 (de) | 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren | |
| WO2005079391A3 (en) | Contrast agents for myocardial perfusion imaging | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| TR200101673A2 (tr) | Düz kas hücrelerinin sıkışmasıyla ilgili hastalıkların tedavisindeki kompozisyonlar için biyokimyasal maddeler. | |
| SG152254A1 (en) | Contrast agents for myocardial perfusion imaging | |
| ATE384519T1 (de) | Hemmer-darstellende mittel | |
| ATE376428T1 (de) | Metallkomplexverbindungen | |
| ATE449847T1 (de) | Hepatitis c rezeptorprotein cd81 | |
| ATE310736T1 (de) | Verbindungen zur bilddarstellung der alzheimer- krankenheit | |
| ATE480552T1 (de) | Stq-peptide | |
| WO2005049095A3 (en) | Contrast agent imaging angiotensin ii receptors | |
| CY1106950T1 (el) | Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων | |
| WO2007064661A3 (en) | Bifunctional metal chelating conjugates | |
| EP1573055A4 (de) | Genetische depressionsdiagnose | |
| DK1485090T3 (da) | Kombinationer omfattende et epothilonderivat og en imidazotetrazinon | |
| HN2002000112A (es) | Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma. | |
| TW200628170A (en) | Contrast agents for myocardial perfusion imaging |